Source: Annual Congress 2009 - Biomarkers and biology in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Casanova, J. P. De Torres, J. Navarro, A. Aguirre-Jaime, P. Toledo, E. Cordova, R. Baz, B. Celli (Santa Cruz de Tenerife, Pamplona, Spain; Boston, United States Of America). Microalbuminuria in patients with COPD: prevalence and correlations with pulmonary parameters. Eur Respir J 2009; 34: Suppl. 53, 439

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Study of microalbuminuria in COPD patients and its association with cardiac comorbidities Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017 Year: 2017 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Pulmonary hemodynamics and clinical manifestations of COPD patients: is there a relationship? Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Pulmonary hypertension in COPD: Prevalence and characteristics Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Comorbidities in patients with COPD: Associations with clinically relevant parameters Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 COPD incidence in subjects with risk factors, chronic respiratory symptoms and normal spirometry: The PLATINO study> Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 CT predictors of pulmonary hypertension in patients with severe COPD Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 24-hour arterial stiffness monitoring values in patients with COPD Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The prevalence of pulmonary hypertension and the related factors in hemodialysis patients Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Correlation of spirometric value to 2D ECHO parameters for diagnosis of pulmonary hypertension in COPD Source: International Congress 2018 – Functional assessment of COPD Year: 2018 emPHasis-10 score predicts mortality in patients with pulmonary hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Individual relationship between weather variables and lung function in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 385s Year: 2005 Haemoglobin level and its clinical impact in a cohort of patients with COPD Source: Eur Respir J 2007; 29: 923-929 Year: 2007 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017